Literature DB >> 1596239

Surgical management of advanced ocular adnexal amyloidosis.

J R Patrinely1, D D Koch.   

Abstract

Ocular adnexal amyloidosis is characterized by amyloid deposition within the deep connective tissue layers of the eyelids, conjunctiva, and anterior orbit. Management of advanced cases has traditionally been unsatisfactory, with either no surgery offered because of fear of hemorrhage or an en bloc resection performed of the entire involved area. We present two cases of advanced periorbital amyloidosis successfully managed by preserving the anatomic planes of the eyelids and meticulously debulking the deposits with a spooned curette. Lax eyelid tendons and aponeuroses were simultaneously repaired, and no sacrifice of eyelid tissues was necessary. One patient remained asymptomatic for 2 years after surgery before developing early reaccumulation in the lower eyelids. The other patient required additional eyelid debulking and ptosis revision 8 months after surgery, but was in stable condition at follow-up 2 years after surgery. This technique offers safe, easily repeatable, nondestructive treatment for advanced periocular amyloidosis.

Entities:  

Mesh:

Year:  1992        PMID: 1596239     DOI: 10.1001/archopht.1992.01080180154045

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

1.  Surgical management of primary localised conjunctival amyloidosis causing ptosis.

Authors:  A D Hubbard; A Brown; R E Bonshek; B Leatherbarrow
Journal:  Br J Ophthalmol       Date:  1995-07       Impact factor: 4.638

2.  Systemic amyloidosis with bilateral conjunctival involvement: a case report.

Authors:  Leandro J Correa; J Pablo Maccio; Evangelina Esposito; Rodolfo Monti; M Eugenia Gonzalez-Castellanos; Martin Paradelo; Horacio M Serra; Julio A Urrets-Zavalia
Journal:  BMC Ophthalmol       Date:  2015-07-19       Impact factor: 2.209

3.  Localized amyloidosis affecting the lacrimal sac managed by endoscopic surgery: A case report.

Authors:  Xiao-Le Song; Jing-Yi Yang; Yu-Ting Lai; Jia-Ying Zhou; Jing-Jing Wang; Xi-Cai Sun; De-Hui Wang
Journal:  World J Clin Cases       Date:  2020-11-26       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.